Drug: WARFARIN SODIUM. Injury: Foetal exposure during pregnancy Quarter: 2016Q3
Total Records: 6 Number of Pages: 1
| Event ID | DRUGNAME | PT | Drug Manufacturer | Patient Age | Sex | Weight | Date (YYYYMMDD) | Country |
|---|---|---|---|---|---|---|---|---|
| 75401594 | WARFARIN SODIUM. | Foetal exposure during pregnancy | BRISTOL MYERS SQUIBB | 0.00 | M | 0 | 20160830 | US |
| 76757043 | WARFARIN SODIUM. | Foetal exposure during pregnancy | BRISTOL MYERS SQUIBB | 0.00 | M | 0 | 20160901 | IN |
| 87016993 | WARFARIN SODIUM. | Foetal exposure during pregnancy | BRISTOL MYERS SQUIBB | 11.00 MON | M | 0 | 20160902 | IN |
| 91325243 | WARFARIN SODIUM. | Foetal exposure during pregnancy | BRISTOL MYERS SQUIBB | 0.00 | M | 0 | 20160902 | GB |
| 115880112 | WARFARIN SODIUM. | Foetal exposure during pregnancy | BRISTOL MYERS SQUIBB | 0.00 | M | 2 KG | 20160901 | ZA |
| 117239503 | WARFARIN SODIUM. | Foetal exposure during pregnancy | BRISTOL MYERS SQUIBB | 0.00 | F | 3 KG | 20160830 | TR |
Total Records: 6 Number of Pages: 1